| Meagan Renee Fazzio, OD | |
|
7024 Siegen Ln, Baton Rouge, LA 70809-4531 | |
| (225) 291-9100 | |
| Not Available |
| Full Name | Meagan Renee Fazzio |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 5 Years |
| Location | 7024 Siegen Ln, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407490998 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1913-849AT (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Louisiana Eye Care | 6204889660 | 4 |
News Archive
Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).
Scientists have warned that we have not seen the end of H1N1 swine flu that swept the globe in 2009/10. The strain of the virus could easily morph into a more transmissible form, while an older, mid-20th century virus could also come roaring back they say. Asian influenza, a H2N2 strain, first appeared in 1957 and killed one to four million people despite a major vaccination campaign. Studies have shown that most people today aged 50 or older retain some immunity to the virus, which continues to circulate in birds and swine. But the younger are more vulnerable they warn.
Increasing numbers of U.S. residents gather and trust health information, including HIV/AIDS information, seen on fictional prime-time television shows, the Los Angeles Times reports.
A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference.
› Verified 9 days ago
| Provider Name | Louisiana Eye Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730363052 PECOS PAC ID: 6204889660 Enrollment ID: O20050225000011 |
News Archive
Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).
Scientists have warned that we have not seen the end of H1N1 swine flu that swept the globe in 2009/10. The strain of the virus could easily morph into a more transmissible form, while an older, mid-20th century virus could also come roaring back they say. Asian influenza, a H2N2 strain, first appeared in 1957 and killed one to four million people despite a major vaccination campaign. Studies have shown that most people today aged 50 or older retain some immunity to the virus, which continues to circulate in birds and swine. But the younger are more vulnerable they warn.
Increasing numbers of U.S. residents gather and trust health information, including HIV/AIDS information, seen on fictional prime-time television shows, the Los Angeles Times reports.
A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meagan Renee Fazzio, OD 10302 Alex Reine Rd, Saint Amant, LA 70774-4428 Ph: () - | Meagan Renee Fazzio, OD 7024 Siegen Ln, Baton Rouge, LA 70809-4531 Ph: (225) 291-9100 |
News Archive
Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).
Scientists have warned that we have not seen the end of H1N1 swine flu that swept the globe in 2009/10. The strain of the virus could easily morph into a more transmissible form, while an older, mid-20th century virus could also come roaring back they say. Asian influenza, a H2N2 strain, first appeared in 1957 and killed one to four million people despite a major vaccination campaign. Studies have shown that most people today aged 50 or older retain some immunity to the virus, which continues to circulate in birds and swine. But the younger are more vulnerable they warn.
Increasing numbers of U.S. residents gather and trust health information, including HIV/AIDS information, seen on fictional prime-time television shows, the Los Angeles Times reports.
A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference.
› Verified 9 days ago
Southern Eye Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7587 Jefferson Hwy, Baton Rouge, LA 70806 Phone: 225-923-0909 Fax: 225-923-0445 | |
Christine D. Norred, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 550 Connells Park Ln, Baton Rouge, LA 70806 Phone: 225-924-2020 Fax: 225-925-0225 | |
Dr. Thomas R Fairley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9001 Summa Ave, Baton Rouge, LA 70809 Phone: 225-761-5200 Fax: 225-761-5618 | |
Premier Eyecare & Optical Optometrist Medicare: Medicare Enrolled Practice Location: 11331 Old Hammond Hwy, Suite B, Baton Rouge, LA 70816 Phone: 225-246-8830 Fax: 225-248-6097 | |
Eyeconic View Eyecare Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2001 Millerville Rd, Baton Rouge, LA 70816 Phone: 225-293-7141 Fax: 225-293-2840 | |
Dr. Kiet T Huynh, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9343 Florida Blvd, (inside Vision For Less), Baton Rouge, LA 70815 Phone: 225-952-9038 Fax: 225-952-9039 | |
Dr. Andrew Kumar Ganesh, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7515 Florida Blvd, Baton Rouge, LA 70806 Phone: 225-924-5460 Fax: 225-924-0988 |